Preferred
(EDT)
Other
Emerging Technologies II
Driving Precision Medicine through Clinical Computational Oncology
9:00 AM - 9:25 AM EDT
Wednesday, June 23, 2021Speaker
Priti Hegde, PhD
Foundation Medicine
Emerging Technologies II
Organotypic Modeling of Cancer and Immune Cell Dynamics
9:25 AM - 9:50 AM EDT
Wednesday, June 23, 2021Speaker
Russell Jenkins, MD, PhD
Massachusetts General Hospital
Emerging Technologies II
Inferring and Making Sense Out of Cancer Cell Phylogenies
9:50 AM - 10:15 AM EDT
Wednesday, June 23, 2021Speaker
Nir Yosef, PhD
University of California, Berkeley
Emerging Technologies II
Targeted Protein Degradation- A New Approach for Challenging Targets
10:15 AM - 10:40 AM EDT
Wednesday, June 23, 2021Speaker
Nathanael Gray, PhD
Stanford University
Emerging Technologies II
Short Talk: MLL-Menin Inhibition Reverses Pre-leukemic Progenitor Self-renewal in NPM1 Mutant AML
10:40 AM - 10:55 AM EDT
Wednesday, June 23, 2021Speaker
Hannah Uckelmann, PhD
Dana-Farber Cancer Institute
Emerging Technologies II
